Roche
An Access Strategy Lead (Oncology) in Global Access at Roche is a strategic expert who ensures access considerations are embedded across development and commercialization to enable rapid, broad, and sustainable patient access. The role partners with cross-functional global and local teams to translate market, payer, and evidence insights into disease-area access briefs and integrated evidence packages. The ASL serves as the primary access point on commercial leadership teams and guides adoption of access strategies across markets.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1896
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roche.
Roche didn’t post a salary, so this is our estimate from similar listings.
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
Access & Pricing Strategy Lead
UCB
Access & Pricing Strategy Lead
UCB
Senior Director, Global Value, Access & Pricing NSCLC Oncology
Revolution Medicines
(Senior) Pricing and Access Manager - Oncology
Digital Biology
Market Access Manager Oncology
AstraZeneca
Director, Global Market Access and Pricing Strategy Oncology – Pumitamig
Bristol Myers Squibb